FDA
approval
· 2026-08-17
FDA Approved: ROSUVASTATIN — Supplemental Application (Camber Pharmaceuticals, Inc.)
Summary
FDA supplemental application approval for Camber Pharmaceuticals' rosuvastatin product.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for ROSUVASTATIN (ROSUVASTATIN)